Author:
de Vos Dick,van Overveld Wendy
Publisher
Springer Science and Business Media LLC
Subject
Hematology,General Medicine
Reference51 articles.
1. Abbruzzese J, Raber M, Vrijhof W et al (1991) A phase I trial of laboratory derived synergistic chemotherapeutic (sc) combination: 2′ deoxy-5-azacytidine (DAC) and cisplatin (CDDP). Proc Am Assoc Cancer Res 32:204 (abstr 1219)
2. Abele R, Clavel M, Dodion P, Bruntsch U, Gundersen S, Smyth J, Renard J, van Glabbeke M, Pinedo HM (1987) The EORTC early clinical trials group experience with 5-aza-2′-deoxycytidine (NSC 127716) in patients with colorectal, head and neck, renal carcinomas and malignant melanomas. Eur J Cancer 23:1921–1924
3. Aparicio A, Eads CA, Leong LA et al (2003) Phase I trial of continuous infusion 5-aza-2′-deoxycytidine. Cancer Chemother Pharmacol 51:231–239
4. Bosch van den J, Lübbert M, Verhoef G (2004) The effects of 5-aza-2′-deoxycytidine (decitabine) on the platelet count in patients with intermediate and high-risk myelodysplastic syndromes. Leuk Res 28:785–790
5. Bouchard J, Momparler RL (1983) Incorporation of 5-aza-2′-deoxycytidine 5′-triphosphate into DNA. Interactions with mammalian DNA polymerase and DNA methylase. Mol Pharmacol 24:109–114
Cited by
46 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献